Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideko Yamauchi

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Breast Cancer (Tokyo, Japan)|February 20, 2021
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer SocietyTakahiko Kawate, Atsushi Yoshida, Sadatoshi Sugae, et al.
Clinical Breast Cancer|December 11, 2013
Prospective study of the effect of the 21-gene assay on adjuvant clinical decision-making in Japanese women with estrogen receptor-positive, node-negative, and node-positive breast cancerHideko Yamauchi, Chizuko Nakagawa, Hiroyuki Takei, et al.
Japanese Journal of Radiology|January 10, 2023
The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccinationKiyoko Mukai, Hiroko Tsunoda, Ryosuke Imai, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2023
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trialHideko Yamauchi, Masakazu Toi, Shin Takayama, et al.
American Journal of Surgery|February 3, 2009
The availability of circulating blood volume values alters fluid management in critically ill surgical patientsDanny M Takanishi, Elisabeth N Biuk-Aghai, Mihae Yu, et al.
Breast Cancer Research and Treatment|March 7, 2020
Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancerMadoka Iwase, Masashi Ando, Kenjiro Aogi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasiaVered Stearns, Andrew Coop, Baljit Singh, et al.
Clinical Breast Cancer|February 2, 2021
Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate ReconstructionYuji Yamashita, Hiroko Tsunoda, Naomi Nagura, et al.
Japan Journal of Nursing Science : JJNS|September 3, 2021
Anxiety and related factors among parents of patients with breast cancer after surgery in Japan: A multi-informant and multilevel studyRei Oshiro, Takafumi Soejima, Keiichiro Tada, et al.
Clinical Breast Cancer|October 23, 2012
Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrenceAtsushi Yoshida, Naoki Hayashi, Futoshi Akiyama, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Breast Cancer (Tokyo, Japan)|February 20, 2021
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer SocietyTakahiko Kawate, Atsushi Yoshida, Sadatoshi Sugae, et al.
Clinical Breast Cancer|December 11, 2013
Prospective study of the effect of the 21-gene assay on adjuvant clinical decision-making in Japanese women with estrogen receptor-positive, node-negative, and node-positive breast cancerHideko Yamauchi, Chizuko Nakagawa, Hiroyuki Takei, et al.
Japanese Journal of Radiology|January 10, 2023
The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccinationKiyoko Mukai, Hiroko Tsunoda, Ryosuke Imai, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2023
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trialHideko Yamauchi, Masakazu Toi, Shin Takayama, et al.
American Journal of Surgery|February 3, 2009
The availability of circulating blood volume values alters fluid management in critically ill surgical patientsDanny M Takanishi, Elisabeth N Biuk-Aghai, Mihae Yu, et al.
Breast Cancer Research and Treatment|March 7, 2020
Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancerMadoka Iwase, Masashi Ando, Kenjiro Aogi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasiaVered Stearns, Andrew Coop, Baljit Singh, et al.
Clinical Breast Cancer|February 2, 2021
Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate ReconstructionYuji Yamashita, Hiroko Tsunoda, Naomi Nagura, et al.
Japan Journal of Nursing Science : JJNS|September 3, 2021
Anxiety and related factors among parents of patients with breast cancer after surgery in Japan: A multi-informant and multilevel studyRei Oshiro, Takafumi Soejima, Keiichiro Tada, et al.
Clinical Breast Cancer|October 23, 2012
Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrenceAtsushi Yoshida, Naoki Hayashi, Futoshi Akiyama, et al.
Pageof 13